Share on LinkedInShare on LinkedIn

ARTICLE · 27 JUNE 2014

USPTO Proposes Revised Patent Term Adjustment Rules For RCEs Under Novartis

The USPTO has published proposed rules for calculating Patent Term Adjustment for applications in which a Request for Continued Examination has been filed.

United StatesIntellectual Property

The USPTO has published proposed rules for calculating Patent Term Adjustment (PTA) for applications in which a Request for Continued Examination (RCE) has been filed, after the Federal Circuit held in Novartis v. Lee that the USPTO's original rules were not consistent with the PTA statute. While the proposed rules appear to follow the Federal Circuit decision for applications which proceed directly to grant, they go further than Novartis by addressing what happens when prosecution is reopened after allowance. The USPTO will consider written comments on the proposed rules received by August 18, 2014.

The Statute at Issue

The statute at issue is 35 USC § 154(b)(1)(B)(i), which provides:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from